Key points are not available for this paper at this time.
THE SPECIFIC therapeutic effect of lithium in manic phases of the manicdepressive psychosis was first observed in 19491and was confirmed later in controlled studies,2,3as well as in a number of uncontrolled ones. A prophylactic action of the drug against both the manic and depressive phases of the illness could be noted in a few of the patients described by Schou et al.2More systematic and detailed observations of this effect were made independently by Hartigan4and Baastrup,5and the termnormothymoticswas proposed for drugs with a specific action against manic-depressive psychosis.6 In order to demonstrate prophylactic drug action in a disorder such as manicdepressive psychosis, which is characterized by a capricious and largely unpredictable course, one must study a large number of patients who have a sufficiently high risk of relapse and who are observed for
Poul Christian Baastrup (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: